Trademark: 87470376
Word
TANDEM
Status
Dead
Status Code
606
Status Date
Monday, July 13, 2020
Serial Number
87470376
Mark Type
4000
Filing Date
Wednesday, May 31, 2017
Published for Opposition
Tuesday, April 17, 2018
Abandoned Date
Monday, July 13, 2020

Trademark Owner History
VARIAN MEDICAL SYSTEMS, INC. - 1st New Owner After Publication
Boston Scientific Limited - Owner At Publication

Classifications
10 Medical devices for embolization, namely, syringes and vials filled with embolic microspheres for embolization; Medical devices for embolization, namely, embolic microspheres for embolization in the form of particles; Medical devices for embolization, namely, embolic microspheres in the form of particles to slow or block blood flow for mediating devascularizations; Medical devices for embolization, namely, embolic microspheres in the form of particles to block blood flow throughout the vasculature system; Medical devices for embolization, namely, embolic microspheres in the form of particles to treat hemorrhages, arteriovenous malformations, hemangioendothelioma, cerebral aneurysms, muscle hypertrophy, hypertrophic cardiomyopathy, gastrointestinal bleeding, trauma, epistaxis, bone cysts, bone metastases, vertebral metastases, varicoceles, congenital hemangioma, artiovenous fistulae, vena cava, vascular anomalies, priapism, prostatic hematuria, hemoptysis, hemorrhagic cystitis, and post-partum hemorrhage; Medical devices for embolization, namely, embolic microspheres in the form of particles to prevent or reduce blood flow through any tissue or organ of interest in order to reduce the growths of hypervascular tissues or malignant cells, tumors, lesions, hepatocellular carcinoma, and fibroids; Medical devices for embolization, namely, embolic microspheres in the form of particles to treat vascular conditions; Medical microspheres for transarterial embolization of tumors, chemoembolization, transarterial chemoembolization, lesion devascularization, lobe devascularization, and proximal embolization; Medical microspheres for the treatment of hypervascular tumors and arteriovenous malformations; Medical microspheres for super selective, targeted chemoembolization of a hypervascular tissue or tumor; Drug delivery device, namely, a drug delivery microsphere for carrying pharmaceuticals or drugs to a precise vasculature bed for localized treatment; Drug delivery device, namely, a drug delivery bead for carrying pharmaceuticals or drugs to a precise vasculature bed for localized treatment

Trademark Events
Jul 13, 2020
Abandonment Notice E-Mailed - No Use Statement Filed
Jul 13, 2020
Abandonment - No Use Statement Filed
Feb 5, 2020
Automatic Update Of Assignment Of Ownership
Dec 10, 2019
Notice Of Approval Of Extension Request E-Mailed
Dec 8, 2019
Extension 3 Granted
Dec 8, 2019
Extension 3 Filed
Dec 8, 2019
Teas Extension Received
Nov 6, 2019
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 6, 2019
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
May 15, 2019
Notice Of Approval Of Extension Request E-Mailed
May 14, 2019
Extension 2 Granted
May 8, 2019
Extension 2 Filed
May 14, 2019
Case Assigned To Intent To Use Paralegal
May 8, 2019
Teas Extension Received
Nov 29, 2018
Notice Of Approval Of Extension Request E-Mailed
Nov 27, 2018
Extension 1 Granted
Nov 27, 2018
Extension 1 Filed
Nov 27, 2018
Teas Extension Received
Jun 12, 2018
Noa E-Mailed - Sou Required From Applicant
Apr 17, 2018
Official Gazette Publication Confirmation E-Mailed
Apr 17, 2018
Published For Opposition
Mar 28, 2018
Notification Of Notice Of Publication E-Mailed
Mar 12, 2018
Approved For Pub - Principal Register
Feb 23, 2018
Teas/Email Correspondence Entered
Feb 22, 2018
Correspondence Received In Law Office
Feb 22, 2018
Teas Response To Office Action Received
Aug 29, 2017
Notification Of Non-Final Action E-Mailed
Aug 29, 2017
Non-Final Action E-Mailed
Aug 29, 2017
Non-Final Action Written
Aug 29, 2017
Assigned To Examiner
Jun 7, 2017
New Application Office Supplied Data Entered In Tram
Jun 3, 2017
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24